{"id":"NCT00500656","sponsor":"Shire","briefTitle":"Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary Angioedema (HAE)","officialTitle":"Randomised Double Blind, Controlled, Parallel Group, Multicentre Study of a Subcutaneous Formulation of Icatibant Versus Oral Tranexamic Acid for the Treatment of Hereditary Angioedema (HAE)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-03-01","primaryCompletion":"2006-07-25","completion":"2006-07-25","firstPosted":"2007-07-13","resultsPosted":"2014-06-09","lastUpdate":"2021-06-09"},"enrollment":85,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Hereditary Angioedema"],"interventions":[{"type":"DRUG","name":"Icatibant","otherNames":["Brand name, Firazyr®"]},{"type":"DRUG","name":"Tranexamic Acid","otherNames":[]},{"type":"DRUG","name":"Oral Placebo","otherNames":["Placebo"]},{"type":"DRUG","name":"S.C. Placebo","otherNames":["Placebo"]}],"arms":[{"label":"Randomized controlled -Icatibant","type":"EXPERIMENTAL"},{"label":"Randomized controlled-Tranexamic acid","type":"ACTIVE_COMPARATOR"},{"label":"Controlled Open-label / laryngeal attack","type":"EXPERIMENTAL"},{"label":"Untreated patients at the baseline","type":"EXPERIMENTAL"}],"summary":"Primary Outcome Measures:\n\nThe primary endpoint was the time to onset of symptom relief of the first attack in the double blind phase. H0: λ icatibant/λ tranexamic acid =1 versus H1: λ icatibant/λ tranexamic acid ≠1 Where: λ icatibant refers to the hazard rate under icatibant and λ tranexamic acid refers to the hazard rate under tranexamic acid.\n\nSecondary Outcome Measures:\n\n* Additional efficacy assessments (Time to Almost Complete Symptom Relief)\n* Safety and tolerability\n* Pharmacoeconomics","primaryOutcome":{"measure":"Time to Onset of Symptom Relief.","timeFrame":"2 days","effectByArm":[{"arm":"Randomized Controlled -Icatibant","deltaMin":2,"sd":null},{"arm":"Randomized Controlled-Tranexamic Acid","deltaMin":12,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"< 0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":12},"locations":{"siteCount":1,"countries":["Italy"]},"refs":{"pmids":["17073887","24111645","20818888"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":36},"commonTop":["Hereditary Angioedema","Nasopharyngitis","Injury, poisoning and procedual complications","Urinary Track Infection","Musculoskeletal and connective tissue disorders"]}}